Robert Seid
12Patents
6h-index
35Co-inventors
66Inventor score
Filing activity: Sep 1, 1988 → Apr 22, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7118757B1 | Meningococcal class 1 outer-membrane protein vaccine | Emerging Cross-Sectional Technologies | 40 | Expired |
| US7935787B2 | Formulations which stabilize and inhibit precipitation of immunogenic compositions | Human Necessities | 18 | Active |
| US8765148B2 | 1C31 nanoparticles | Emerging Cross-Sectional Technologies | 17 | Active |
| US5098997A | Vaccines for Haemophilus influenzae | Emerging Cross-Sectional Technologies | 16 | Expired |
| US8562999B2 | Formulations which stabilize and inhibit precipitation of immunogenic compositions | Human Necessities | 12 | Active |
| US6638513B2 | Neisseria meningitidis serogroup B Glycoconjugates | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7238345B1 | Recombinant microorganism expressing meningococcal class 1 outer membrane protein | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5196338A | Recombinant vectors for Haemophilus influenzae peptides and proteins | Chemistry; Metallurgy | 2 | Expired |
| US8293275B2 | Spray freeze dry of compositions for pulmonary administration | Human Necessities | 1 | Active |
| US7923029B2 | Spray freeze dry of compositions for pulmonary administration | Human Necessities | 1 | Active |
| US7169392B2 | Neisseria meningitidis serogroup B glycoconjugates and methods of producing the same | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9248180B2 | IC31 nanoparticles | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.